540 related articles for article (PubMed ID: 15289635)
1. Adverse drug events and medication errors: detection and classification methods.
Morimoto T; Gandhi TK; Seger AC; Hsieh TC; Bates DW
Qual Saf Health Care; 2004 Aug; 13(4):306-14. PubMed ID: 15289635
[TBL] [Abstract][Full Text] [Related]
2. Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.
Kunac DL; Reith DM; Kennedy J; Austin NC; Williams SM
Qual Saf Health Care; 2006 Jun; 15(3):196-201. PubMed ID: 16751470
[TBL] [Abstract][Full Text] [Related]
3. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
[TBL] [Abstract][Full Text] [Related]
4. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit.
Buckley MS; Erstad BL; Kopp BJ; Theodorou AA; Priestley G
Pediatr Crit Care Med; 2007 Mar; 8(2):145-52. PubMed ID: 17273111
[TBL] [Abstract][Full Text] [Related]
5. Identifying drug safety issues: from research to practice.
Gandhi TK; Seger DL; Bates DW
Int J Qual Health Care; 2000 Feb; 12(1):69-76. PubMed ID: 10733086
[TBL] [Abstract][Full Text] [Related]
6. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
Kunac DL; Kennedy J; Austin N; Reith D
Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study.
Sakuma M; Ida H; Nakamura T; Ohta Y; Yamamoto K; Seki S; Hiroi K; Kikuchi K; Nakayama K; Bates DW; Morimoto T
BMJ Qual Saf; 2014 Oct; 23(10):830-7. PubMed ID: 24742779
[TBL] [Abstract][Full Text] [Related]
9. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
[TBL] [Abstract][Full Text] [Related]
10. Methods for assessing the preventability of adverse drug events: a systematic review.
Hakkarainen KM; Andersson Sundell K; Petzold M; Hägg S
Drug Saf; 2012 Feb; 35(2):105-26. PubMed ID: 22201475
[TBL] [Abstract][Full Text] [Related]
11. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
Kunac DL; Tatley MV
Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
[TBL] [Abstract][Full Text] [Related]
12. A targeted method for standardized assessment of adverse drug events in surgical patients.
de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of preventable adverse drug events: a review of the literature.
von Laue NC; Schwappach DL; Koeck CM
Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
[TBL] [Abstract][Full Text] [Related]
14. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index.
Snyder RA; Abarca J; Meza JL; Rothschild JM; Rizos A; Bates DW
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1006-13. PubMed ID: 17523185
[TBL] [Abstract][Full Text] [Related]
15. Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.
Tenhunen ML; Smithers B; Tucker B
Consult Pharm; 2016; 31(8):436-9. PubMed ID: 27535078
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Literature Review of Factors Influencing Medication Safety in Nursing Homes: Using a Systems Model.
Al-Jumaili AA; Doucette WR
J Am Med Dir Assoc; 2017 Jun; 18(6):470-488. PubMed ID: 28242191
[TBL] [Abstract][Full Text] [Related]
17. Medication safety program reduces adverse drug events in a community hospital.
Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
[TBL] [Abstract][Full Text] [Related]
18. Inter-rater reliability of a classification system for hospital adverse drug event reports.
Haynes K; Hennessy S; Morales KH; Gibson GA; Barnhart C; Jaipaul CK; Linkin DR
Clin Pharmacol Ther; 2008 Mar; 83(3):485-8. PubMed ID: 17713472
[TBL] [Abstract][Full Text] [Related]
19. Strategies for detecting adverse drug events among older persons in the ambulatory setting.
Field TS; Gurwitz JH; Harrold LR; Rothschild JM; Debellis K; Seger AC; Fish LS; Garber L; Kelleher M; Bates DW
J Am Med Inform Assoc; 2004; 11(6):492-8. PubMed ID: 15299000
[TBL] [Abstract][Full Text] [Related]
20. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
